Publications dans lesquelles il/elle collabore avec Claudia Augusta Di Trani (19)

2024

  1. Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

2023

  1. Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models

    Oncoimmunology, Vol. 12, Núm. 1, pp. 2147317

  2. Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis

    Journal for immunotherapy of cancer, Vol. 11, Núm. 11

  3. Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity

    Cancer immunology research, Vol. 11, Núm. 2, pp. 184-198

  4. Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists

    Molecular Therapy - Nucleic Acids, Vol. 33, pp. 668-682

  5. Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure

    Molecular Therapy - Nucleic Acids, Vol. 33, pp. 599-616

  6. Tailoring the bioactivities of IL-12 for cancer immunotherapy with mRNA-based technology: from immunocytokines to armored T cell transfer

    Tailoring the bioactivities of IL-12 for cancer immunotherapy with mRNA-based technology: from immunocytokines to armored T cell transfer

2022

  1. Advances in mRNA-based drug discovery in cancer immunotherapy

    Expert Opinion on Drug Discovery, Vol. 17, Núm. 1, pp. 41-53

  2. Novel strategies exploiting interleukin-12 in cancer immunotherapy

    Pharmacology and Therapeutics, Vol. 239

  3. Omentum: Friend or foe in ovarian cancer immunotherapy?

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 117-131

  4. Overcoming the limitations of cytokines to improve cancer therapy

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 107-141

  5. Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis

    OncoImmunology, Vol. 11, Núm. 1

2021

  1. Mouse models of peritoneal carcinomatosis to develop clinical applications

    Cancers, Vol. 13, Núm. 5, pp. 1-11

  2. Statins act as transient type i interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 7

2020

  1. Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice

    Frontiers in Pharmacology, Vol. 11

  2. Interleukin-12 message in a bottle

    Clinical Cancer Research, Vol. 26, Núm. 23, pp. 6080-6082

  3. Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity

    Frontiers in Immunology, Vol. 11

  4. Scavenger Receptor Class B Type I is Required for 25-Hydroxycholecalciferol Cellular Uptake and Signaling in Myeloid Cells

    Molecular Nutrition and Food Research, Vol. 64, Núm. 15

2019

  1. Treatment of experimental autoimmune encephalomyelitis by sustained delivery of low-dose IFN-a

    Journal of Immunology, Vol. 203, Núm. 3, pp. 696-704